Key Findings

Key Findings (continued)

Scope and Segmentation

Market Segmentation

Market Segmentation (continued)

Key Questions This Study Will Answer

Market Engineering Measurements

CEO’s Perspective

Key Companies to Watch

Executive Summary—Three Big Predictions

Market Segmentation

Market Segmentation (continued)

Segmentation by Tiers of Competition

Segmentation by Tiers of Competition (continued)

New Market Opportunities

New Market Opportunities (continued)

Key Merger, Acquisition, and Partnership Assessment

Key Merger, Acquisition, and Partnership Assessment (continued)

Market Drivers

Drivers Explained

Drivers Explained (continued)

Drivers Explained (continued)

Drivers Explained (continued)

Market Restraints

Restraints Explained

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Restraints Explained (continued)

Market Impact of Key Drivers and Restraints

Market Engineering Measurements

Forecast Assumptions and Definitions

Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Per Cent Revenue Forecast by Region

Revenue Forecast by Region

Ghana & Nigeria—Therapeutic Segment Growth Analysis

Procurement Process

Ghanaian Pharmaceutical Industry Overview

Ghanaian Pharmaceutical Industry Overview (continued)

Ghana—Health Profile

Ghana—Malaria

Ghana—Malaria (continued)

Ghana—Malaria (continued)

Ghana—Tuberculosis (TB)/HIV

Ghana—Tuberculosis (TB)/HIV (continued)

Ghana—Tuberculosis (TB)/HIV (continued)

Ghana—Non-communicable Diseases (NCDs)

Ghana—Non-communicable Diseases (continued)

Ghana—Non-communicable Diseases (continued)

Ghana—Non-communicable Diseases (continued)

Ghanaian Pharmaceutical Industry

Ghanaian Pharmaceutical Industry—Market Engineering Measurements

Ghanaian Pharmaceutical Industry—Revenue Forecast

Ghanaian Pharmaceutical Industry—Revenue Forecast Discussion

Ghanaian Pharmaceutical Industry—Revenue Forecast Discussion (continued)

Ghana—Per Cent Revenue Forecast by Product Segment

Ghana—Per Cent Revenue Forecast by Therapeutic Segment

OTC Pharmaceuticals Segment—Revenue Forecast

OTC Pharmaceuticals Segment—Revenue Forecast Discussion

Generic Pharmaceuticals Segment—Revenue Forecast

Generic Pharmaceuticals Segment—Revenue Forecast Discussion

Branded Pharmaceuticals Segment—Revenue Forecast

Branded Pharmaceuticals Segment—Revenue Forecast Discussion

Anti-infectives Segment—Revenue Forecast

Anti-infectives Segment—Revenue Forecast Discussion

Anti-infectives Segment—Revenue Forecast Discussion (continued)

Anti-infectives Segment—Revenue Forecast Discussion (continued)

Cardiovascular Segment—Revenue Forecast

Cardiovascular Segment—Revenue Forecast Discussion

Diabetes Segment—Revenue Forecast

Diabetes Segment—Revenue Forecast Discussion

Respiratory Segment—Revenue Forecast

Respiratory Segment—Revenue Forecast Discussion

CNS Segment—Revenue Forecast

CNS Segment—Revenue Forecast Discussion

Oncology Segment—Revenue Forecast

Oncology Segment—Revenue Forecast Discussion

Pricing Analysis

Pricing Analysis (continued)

Pricing Analysis (continued)

Ghanaian Pharmaceutical Industry—SWOT Analysis

PESTLE Analysis

Regulatory Analysis

Ghanaian Pharmaceutical Industry—Procurement and Supply Management

Ghanaian Pharmaceutical Industry—Procurement and Supply Management (continued)

Ghanaian Pharmaceutical Industry—Distribution

Ghanaian Pharmaceutical Industry—Distribution (continued)

Ghanaian Pharmaceutical Industry—Retail

Ghanaian Pharmaceutical Industry—Demand Analysis

Ghanaian Pharmaceutical Industry—Demand Analysis (continued)

Competitive Environment

Competitive Environment (continued)

Ghanaian Pharmaceutical Industry—Competitor AnalysisMultinationals

Ghanaian Pharmaceutical Industry—Competitor AnalysisGeneric Companies

Ghanaian Pharmaceutical Industry—Competitor AnalysisLocal Manufacturers

Ghanaian Pharmaceutical Industry—Competitor ProfileErnest Chemists Limited

Ghanaian Pharmaceutical Industry—Competitor ProfileKinapharma Limited

Ghanaian Pharmaceutical Industry—Competitor ProfilePhyto-Riker (GIHOC) Pharmaceutical Limited

Ghanaian Pharmaceutical Industry—Competitor ProfileAyrton Drugs Manufacturing Company Limited

Ghanaian Pharmaceutical Industry—Competitor ProfileKama Group Limited

Nigerian Pharmaceutical Industry Overview

Nigerian Pharmaceutical Industry Overview (continued)

Nigeria—Health Profile

Nigeria—Malaria

Nigeria—Malaria (continued)

Nigeria—Malaria (continued)

Nigeria—Tuberculosis (TB)/HIV

Nigeria—Tuberculosis (TB)/HIV (continued)

Nigeria—Tuberculosis (TB)/HIV (continued)

Nigeria—Non-communicable Diseases (NCDs)

Nigeria—Non-communicable Diseases (continued)

Nigeria—Non-communicable Diseases (continued)

Nigeria—Non-communicable Diseases (continued)

Nigerian Pharmaceutical Industry

Nigerian Pharmaceutical Industry—Market Engineering Measurements

Nigerian Pharmaceutical Industry—Revenue Forecast

Nigerian Pharmaceutical Industry—Revenue Forecast Discussion

Nigerian Pharmaceutical Industry—Revenue Forecast Discussion (continued)

Nigeria—Per Cent Revenue Forecast by Product Segment

Nigeria—Per Cent Revenue Forecast by Product and Therapeutic Segment

OTC Pharmaceuticals Segment—Revenue Forecast

OTC Pharmaceuticals Segment—Revenue Forecast Discussion

Generic Pharmaceuticals Segment—Revenue Forecast

Generic Pharmaceuticals Segment—Revenue Forecast Discussion

Branded Pharmaceuticals Segment—Revenue Forecast

Branded Pharmaceuticals Segment—Revenue Forecast Discussion

Anti-infectives Segment—Revenue Forecast

Anti-infectives Segment—Revenue Forecast Discussion

Anti-infectives Segment Revenue—Forecast Discussion (continued)

Anti-infectives Segment—Revenue Forecast Discussion (continued)

Cardiovascular Segment—Revenue Forecast

Cardiovascular Segment—Revenue Forecast Discussion

Diabetes Segment—Revenue Forecast

Diabetes Segment—Revenue Forecast Discussion

Respiratory Segment—Revenue Forecast

Respiratory Segment—Revenue Forecast Discussion

CNS Segment—Revenue Forecast

CNS Segment—Revenue Forecast Discussion

Oncology Segment—Revenue Forecast

Oncology Segment—Revenue Forecast Discussion

Pricing Analysis

Pricing Analysis (continued)

Nigerian Pharmaceutical Industry—SWOT Analysis

PESTLE Analysis

Regulatory Analysis

Regulatory Analysis (continued)

Nigerian Pharmaceutical Industry—Procurement and Supply Management

Nigerian Pharmaceutical Industry—Procurement and Supply Management (continued)

Nigerian Pharmaceutical Industry—Distribution

Nigerian Pharmaceutical Industry—Distribution (continued)

Nigerian Pharmaceutical Industry—Demand Analysis

Ghanaian Pharmaceutical Industry—Demand Analysis (continued)

Ghanaian Pharmaceutical Industry—Demand Analysis (continued)

Competitive Environment

Competitive Environment (continued)

Nigerian Pharmaceutical Industry—Competitor AnalysisMultinationals

Nigerian Pharmaceutical Industry—Competitor AnalysisGeneric Companies

Nigerian Pharmaceutical Industry—Competitor AnalysisLocal Manufacturers

Nigerian Pharmaceutical Industry—Competitor ProfileEmzor Pharmaceutical Industries Limited

Nigerian Pharmaceutical Industry—Competitor ProfileFidson Healthcare PLC

Nigerian Pharmaceutical Industry—Competitor ProfileMay & Baker Nigeria PLC

Nigerian Pharmaceutical Industry—Competitor ProfileEvans Medical PLC

Nigerian Pharmaceutical Industry—Competitor ProfileNigeria German Chemicals PLC

Key Companies to Watch

The Last Word—Three Big Predictions

The Last Word—Discussion

The Last Word—Discussion (continued)

The Last Word—Discussion (continued)

Legal Disclaimer

Market Background

Important Market Metrics

Market Landscape and Pricing

Decision Support Database—Total Healthcare Expenditure

Decision Support Database—Total Healthcare Expenditure (continued)

Decision Support Database—Public Healthcare Expenditure

Decision Support Database—Public Healthcare Expenditure (continued)

Decision Support Database—Private Healthcare Expenditure

Decision Support Database—Private Healthcare Expenditure (continued)

Other Related Research Services

List of Other Key Companies Included in this Research Service

Market Engineering Methodology

Learn More—Next Steps